Achieve Life Sciences Inc (ACHV) Stock Price, Quote & News

Company Profile

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothel...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 210 2217

Website: www.achievelifesciences.com

Address:

22722 29th Dr. SE, Suite 100, Bothell, United States

VCV86 Jul. 2 at 2:59 PM

$UNCY $CING $ACHV if you like post-CMC CRL setups, $GRCE looks like a great opportunity here. The stock has been hammered, and FDA alignment after the Type A meeting could come anytime.

3 · Reply

Ghostrider2020 Jul. 2 at 12:36 PM

$ACHV does anyone know when or if the shares will be margin eligible?

2 · Reply

Mugshot Jul. 1 at 7:36 PM

$ACHV healthy pull back

1 · Reply

V106GuY Jul. 1 at 6:58 PM

$ACHV that's a nice dip..

0 · Reply

Sds3n Jul. 1 at 3:33 PM

$ACHV This is potential candidate for M&A, price target could be around $15

0 · Reply

Greyhound_ Jul. 1 at 2:14 PM

$ACHV We finally have a competent CEO and management team. I personally liked Bencich, I thought he was more transparent than most -- almost to a fault - but I never understood the need for the Sopharma facility as it seemed like a massive risk particularly when Trump was elected. Look at $UNCY -- received a CRL yesterday because its CEO stuck with an Indian facility that was previously deemed to have manufacturing deficits. The FDA didn't even bother to inspect the facility in India again before issuing a blind-side rejection -- clearly their move should have been to move operations to the USA, like Achieve's CEO did. I don't love the probability of a zero-bid contract to Adare based on BoD connections, but that's the business world we operate in today where nobody bats an eye. As long as the FDA is okay with Adare, I am fine if the contract is a bit less advantageous to us than it could have been with an open RFP campaign for a new manufacturer.

2 · Reply

bobtheknob Jul. 1 at 2:09 PM

$ACHV The train has left the station, if $7 holds next stop is near $9

0 · Reply

BG_BULL Jul. 1 at 2:04 PM

$ACHV

0 · Reply

Peepants Jul. 1 at 8:41 AM

$ACHV This is fun.

0 · Reply

zmanx Jul. 1 at 6:38 AM

$ACHV on the verge of a golden cross on the weekly… future looks bright 😄

1 · Reply

Achieve Life Sciences Transcript: AGM 2026

2026-06-29T13:00:47.000Z - 5 days ago

Achieve Life Sciences added to Russell 2000 Index

Jun 29, 2026, 8:30 AM EDT - 5 days ago

Achieve Life Sciences Joins Russell 2000® Index

2026-06-26T12:15:27.000Z - 8 days ago

Achieve Life Sciences resumed with a Strong Buy at Raymond James

2026-06-22T13:45:06.000Z - 12 days ago

Achieve Life Sciences CRL from FDA cites deficiencies at manufacturing facility

Jun 22, 2026, 8:54 AM EDT - 12 days ago

US FDA declines to approve Achieve Life Sciences' smoking-cessation drug

Jun 22, 2026, 8:30 AM EDT - 12 days ago

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Jun 8, 2026, 8:00 AM EDT - 26 days ago

Achieve Life Sciences Proxy statement: Proxy filing

Jun 2, 2026, 8:30 AM EDT - 4 weeks ago

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

May 29, 2026, 8:00 AM EDT - 5 weeks ago

Achieve Life Sciences Proxy statement: Proxy filing

May 19, 2026, 2:15 PM EDT - 6 weeks ago

Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

2026-05-12T21:31:08.000Z - 7 weeks ago

Achieve Life Sciences files prospectus for resale of shares by holders

May 12, 2026, 8:30 AM EDT - 7 weeks ago

Achieve Life Sciences Earnings Call Transcript: Q1 2026

May 12, 2026, 8:30 AM EDT - 7 weeks ago

Achieve Life Sciences Earnings release: Q1 2026

May 12, 2026, 8:30 AM EDT - 7 weeks ago

Achieve Life Sciences Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 7 weeks ago

Achieve Life Sciences Registration statement: Registration filing

2026-05-12T11:58:27.000Z - 7 weeks ago

Achieve Life Sciences reports Q1 EPS (19c), consensus (30c)

May 12, 2026, 7:05 AM EDT - 7 weeks ago

Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma

May 12, 2026, 7:00 AM EDT - 7 weeks ago

Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates

May 5, 2026, 8:30 AM EDT - 2 months ago

Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

May 1, 2026, 7:00 AM EDT - 2 months ago

Achieve Life Sciences Slides: Corporate presentation

2026-04-21T09:20:14.000Z - 2 months ago

Achieve Life Sciences initiated with a Buy at Canaccord

2026-04-20T20:46:40.000Z - 2 months ago

Achieve Life Sciences initiated with a Buy at Canaccord

2026-04-16T15:25:18.000Z - 2 months ago

Achieve Life Sciences announces $354M private placement

2026-04-16T14:03:48.000Z - 2 months ago

Achieve Life Sciences appoints Goldberg as CEO, names two leaders to board

Apr 16, 2026, 8:57 AM EDT - 2 months ago

Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors

Apr 16, 2026, 8:53 AM EDT - 2 months ago

Achieve Life Sciences Announces Up to $354 Million Private Placement

Apr 15, 2026, 8:00 AM EDT - 2 months ago

Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

Mar 26, 2026, 8:30 AM EDT - 3 months ago

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

Mar 24, 2026, 2:23 PM EDT - 3 months ago

Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Mar 24, 2026, 8:30 AM EDT - 3 months ago

Achieve Life Sciences Earnings Call Transcript: Q4 2025

Mar 24, 2026, 8:30 AM EDT - 3 months ago

Achieve Life Sciences Annual report: Q4 2025

Mar 24, 2026, 8:30 AM EDT - 3 months ago

Achieve Life Sciences Earnings release: Q4 2025

2026-03-24T11:10:44.000Z - 3 months ago

Achieve Life Sciences reports Q4 EPS (28c), consensus (28c)

Mar 24, 2026, 7:00 AM EDT - 3 months ago

Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Mar 17, 2026, 8:30 AM EDT - 3 months ago

Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

2026-03-09T20:45:55.000Z - 4 months ago

Aeon Biopharma appoints John Bencich as CFO

AEON

2026-03-04T13:21:27.000Z - 4 months ago

Achieve Life Sciences announces new data on cytisinicline to be presented

Mar 4, 2026, 8:00 AM EST - 4 months ago

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

2026-02-06T16:15:23.000Z - 5 months ago

H.C. Wainwright says Chantix news ‘significant win’ for Achieve Life Sciences

PFE

Jan 30, 2026, 4:05 PM EST - 5 months ago

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

2026-01-23T21:10:26.000Z - 5 months ago

Achieve Life Sciences files $300M mixed securities shelf

Jan 23, 2026, 7:00 AM EST - 5 months ago

Achieve Life Sciences Registration statement: Registration Filing

2026-01-12T13:55:17.000Z - 6 months ago

Achieve Life Sciences confirms promotion of Mark Rubinstein to CMO

Jan 12, 2026, 8:47 AM EST - 6 months ago

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Jan 12, 2026, 7:00 AM EST - 6 months ago

Achieve Life Sciences Slides: Corporate presentation

2026-01-05T16:45:30.000Z - 6 months ago

H.C. Wainwright names two best 2026 ideas in SMID-cap biopharma

CNTB

Dec 17, 2025, 4:11 PM EST - 7 months ago

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

Nov 6, 2025, 8:30 AM EST - 8 months ago

Achieve Life Sciences Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Achieve Life Sciences Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Achieve Life Sciences Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 8 months ago

Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Nov 5, 2025, 7:00 AM EST - 8 months ago

Achieve Life Sciences Slides: Corporate Presentation

Nov 3, 2025, 8:30 AM EST - 8 months ago

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation

Oct 29, 2025, 8:30 AM EDT - 8 months ago

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

Oct 20, 2025, 8:30 AM EDT - 9 months ago

Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

Oct 17, 2025, 7:30 AM EDT - 9 months ago

Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation

Oct 2, 2025, 4:01 PM EDT - 9 months ago

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

Sep 22, 2025, 8:30 AM EDT - 10 months ago

Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline's Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD

Sep 18, 2025, 8:30 AM EDT - 10 months ago

Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer

Sep 11, 2025, 5:01 PM EDT - 10 months ago

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

Sep 8, 2025, 11:00 AM EDT - 10 months ago

Achieve Life Sciences Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 3, 2025, 8:30 AM EDT - 10 months ago

Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation

Sep 2, 2025, 8:30 AM EDT - 10 months ago

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Achieve Life Sciences Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Achieve Life Sciences Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

Achieve Life Sciences Earnings release: Q2 2025

Aug 7, 2025, 7:30 AM EDT - 11 months ago

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Aug 6, 2025, 6:00 PM EDT - 11 months ago

Achieve Life Sciences Slides: Corporate Presentation

Jul 29, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

Jul 24, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Slides: Corporate Presentation

Jun 30, 2025, 7:52 PM EDT - 1 year ago

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities

Jun 26, 2025, 11:43 PM EDT - 1 year ago

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

Jun 26, 2025, 4:03 PM EDT - 1 year ago

Achieve Life Sciences Announces Proposed Underwritten Public Offering

Jun 26, 2025, 4:02 PM EDT - 1 year ago

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

OMC

Jun 4, 2025, 5:30 PM EDT - 1 year ago

Achieve Life Sciences Transcript: Jefferies Global Healthcare Conference 2025

May 28, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

May 20, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake

May 13, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings Call Transcript: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Quarterly report: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings release: Q1 2025

May 13, 2025, 7:30 AM EDT - 1 year ago

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program

May 6, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Achieve Life Sciences Proxy statement: Proxy Filing

Apr 21, 2025, 11:19 AM EDT - 1 year ago

Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine

Mar 12, 2025, 11:30 AM EDT - 1 year ago

Achieve Life Sciences Transcript: Barclays 27th Annual Global Healthcare Conference 2025

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings Call Transcript: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Annual report: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Achieve Life Sciences Earnings release: Q4 2024

Mar 11, 2025, 7:30 AM EDT - 1 year ago

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program

Mar 7, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference

Mar 6, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025

Feb 11, 2025, 10:00 AM EST - 1 year ago

Achieve Life Sciences Transcript: Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025

Feb 11, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference

Feb 10, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial

Jan 10, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

Jan 7, 2025, 8:30 AM EST - 1 year ago

Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission

Dec 9, 2024, 8:30 AM EST - 1 year ago

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

VCV86 Jul. 2 at 2:59 PM

$UNCY $CING $ACHV if you like post-CMC CRL setups, $GRCE looks like a great opportunity here. The stock has been hammered, and FDA alignment after the Type A meeting could come anytime.

3 · Reply

Ghostrider2020 Jul. 2 at 12:36 PM

$ACHV does anyone know when or if the shares will be margin eligible?

2 · Reply

Mugshot Jul. 1 at 7:36 PM

$ACHV healthy pull back

1 · Reply

V106GuY Jul. 1 at 6:58 PM

$ACHV that's a nice dip..

0 · Reply

Sds3n Jul. 1 at 3:33 PM

$ACHV This is potential candidate for M&A, price target could be around $15

0 · Reply

Greyhound_ Jul. 1 at 2:14 PM

2 · Reply

bobtheknob Jul. 1 at 2:09 PM

$ACHV The train has left the station, if $7 holds next stop is near $9

0 · Reply

BG_BULL Jul. 1 at 2:04 PM

$ACHV

0 · Reply

Peepants Jul. 1 at 8:41 AM

$ACHV This is fun.

0 · Reply

zmanx Jul. 1 at 6:38 AM

$ACHV on the verge of a golden cross on the weekly… future looks bright 😄

1 · Reply

BuyHighSellLow66 Jun. 30 at 11:07 PM

$ACHV still got my 5k at 2.11 but man I really shoulda added more at some point 🤣. These shares are going ultra long atleast.

1 · Reply

zmanx Jun. 30 at 6:22 PM

$ACHV new 52wk high made …. and 💯%+ since post. 👏🏾 good job if you stayed patient

1 · Reply

bobtheknob Jun. 30 at 1:23 PM

$ACHV If $6.20 support holds we should be headed closer to $9 over the next few weeks.

3 · Reply

AyemanAyeman Jun. 29 at 9:09 PM

$ACHV I’m almost in the green,.. oh joy

0 · Reply

Mugshot Jun. 29 at 8:27 PM

$ACHV next resistance is7$

0 · Reply

bobtheknob Jun. 29 at 8:10 PM

$ACHV 52 week highs and close above major resistance. How long till we reach $9(my break even)? 🤔

0 · Reply

markwall Jun. 29 at 2:49 PM

$ACHV Not sure what would collapse this stock again to the $3's, seems like bottoms are in and stock will only go sideways or up from here.

1 · Reply

Rvin Jun. 29 at 1:20 PM

$ACHV Achieve Life Sciences Joins Russell 2000® Index SEATTLE and VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced that it has been added to the Russell 2000® Index, effective June 26, 2026, as part of the Russell U.S. Indexes reconstitution. The Company is also a member of the Russell 3000® Index

0 · Reply

OnlyFibs Jun. 28 at 4:19 AM

$ACHV is winding up for a move! As a clinical-stage biotech firm laser-focused on nicotine cessation, their value is tied directly to the progress of cytisinicline. The market is clearly paying attention to the technical structure here as we approach key development milestones. The chart is telegraphing a massive resolution ahead. Stay patient and wait for the volume to pick a side before you make your move. ⚡️🎯 Bull Key Levels: We need a decisive breakout above $6.00 to unlock the next leg higher. 🐂🔥 Bear Key Levels: If $5.40 fails, we could see a quick slide toward the $4.60 support zone. 🐻⚠️ Take Profit Targets: $6.50 / $7.00. 💰💸 #hovdid #Biotech #Healthcare #Trading #Breakout

0 · Reply

zmanx Jun. 27 at 12:19 AM

$ACHV still making solid headway

1 · Reply

V106GuY Jun. 26 at 8:03 PM

$ACHV nice Friday close... Ready for a strong Monday 💪

1 · Reply

Mugshot Jun. 26 at 1:49 PM

$ACHV On June 26, 2026, Achieve Life Sciences science 32 has gained renewed attention as Raymond James reinstated its coverage with a Strong Buy recommendation, setting a price target of $20. The firm's analysis highlights the potential of Achieve's cytisinicline, which, bolstered by data from Phase 2b and Phase 3 ORCA trials, could emerge as the first FDA-approved therapy for smoking cessation in nearly two decades, boasting superior efficacy and safety.

1 · Reply

Market Cap	657.02M
Revenue (ttm)	0.00
Net Income (ttm)	-54.65M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.53

Volume	1,712,900
Avg Vol	1,866,916
Day's Range	N/A - N/A
Shares Out	102.66M
Stochastic %K	68%
Beta	2.21
Analysts	Strong Sell
Price Target	$14.33